Considering the absence of anti-aquaporin-4 (anti-AQP4) or anti-myelin oligodendrocyte glycoprotein (anti-MOG) antibodies in our patient, as well as the absence of clinical or serologic evidence for other systemic autoimmune disease, the leading differential diagnosis in our patient is MS. The gene discussed is AQP4; the disease is myeloid sarcoma.